Illumina, Inc. (NASDAQ: ILMN) has appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, according to a company statement. Sullivan's appointment takes effect July 20, 2026, and Coletti's on August 3, 2026.

Sullivan will lead Illumina's global commercial organization. He has more than 30 years of commercial leadership experience in diagnostics, precision medicine, healthcare, and life sciences. He most recently served as Chief Commercial Officer at Caris Life Sciences, overseeing global commercial operations across oncology diagnostics and precision medicine. Prior to that, he held senior roles at Roche Diagnostics, Ortho Clinical Diagnostics, IDEXX Laboratories, and Abbott Diagnostics.

Coletti will lead Illumina's global legal, regulatory, and government affairs teams and serve as corporate secretary to the Illumina Board of Directors. She previously served as Chief Legal and Regulatory Officer at Align Technology and held senior legal positions at Danaher Corporation and Bayer HealthCare. She also serves as a director for Fortis Life Sciences.

"Mike brings deep commercial expertise, a customer-first mindset, and significant experience scaling global organizations, while Julie is a highly accomplished legal and business leader with deep experience across the life sciences and medical technology sectors," said Jacob Thaysen, chief executive officer of Illumina.